Trial intelligence / Profile preview

Betahistine for Olanzapine-Induced Weight Gain

NCT00428168Phase 2Terminated

Sponsor
Obecure Ltd.
Start
Mar 2007
Primary completion
Aug 2008
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of betahistine, sponsored by Obecure Ltd.. Started Mar 2007; status: terminated.

02

Drugs

betahistine

Beyond the preview

Go deeper on NCT00428168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00428168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call